Victory Capital Management
EDIT icon

Victory Capital Management’s Editas Medicine EDIT Stock Holding History

Victory Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.2K Buy
17,642
+6,499
+58% +$19K ﹤0.01% 2384
2026
Q1 		$27.5K Sell
11,143
-37
-0.3% -$78 ﹤0.01% 2360
2025
Q4 		$22.9K Buy
11,180
+922
+9% +$2.66K ﹤0.01% 2380
2025
Q3 		$35.6K Buy
+10,258
New +$28.6K ﹤0.01% 2370
2025
Q1 		– Sell
-10,115
Closed -$12.8K – 2492
2024
Q4 		$12.8K Sell
10,115
-256
-2% -$652 ﹤0.01% 2464
2024
Q3 		$35.4K Sell
10,371
-201
-2% -$875 ﹤0.01% 2414
2024
Q2 		$49.4K Sell
10,572
-67,899
-87% -$383K ﹤0.01% 2368
2024
Q1 		$582K Buy
78,471
+67,546
+618% +$561K ﹤0.01% 1934
2023
Q4 		$111K Buy
+10,925
New +$95.9K ﹤0.01% 2328
2022
Q1 		– Sell
-1,115,611
Closed -$29.6M – 2745
2021
Q4 		$29.6M Sell
1,115,611
-3,298
-0.3% -$114K 0.03% 772
2021
Q3 		$46M Buy
1,118,909
+1,076,258
+2,523% +$59M 0.05% 577
2021
Q2 		$2.42M Sell
42,651
-2,081
-5% -$76.9K ﹤0.01% 1573
2021
Q1 		$1.88M Sell
44,732
-12,180
-21% -$694K ﹤0.01% 1668
2020
Q4 		$3.99M Sell
56,912
-9,056
-14% -$372K ﹤0.01% 1301
2020
Q3 		$1.85M Buy
65,968
+8,351
+14% +$272K ﹤0.01% 1470
2020
Q2 		$1.7M Sell
57,617
-121,015
-68% -$3.16M ﹤0.01% 1488
2020
Q1 		$3.54M Sell
178,632
-6,878
-4% -$173K 0.01% 1171
2019
Q4 		$5.49M Sell
185,510
-15,830
-8% -$395K 0.01% 1159
2019
Q3 		$4.58M Buy
+201,340
New +$4.99M 0.01% 1185
2019
Q1 		– Sell
-62,002
Closed -$1.41M – 1808
2018
Q4 		$1.41M Buy
62,002
+16,800
+37% +$457K ﹤0.01% 1123
2018
Q3 		$1.44M Sell
45,202
-2,420
-5% -$78.2K ﹤0.01% 1183
2018
Q2 		$1.71M Sell
47,622
-2,670
-5% -$94.5K ﹤0.01% 1111
2018
Q1 		$1.67M Buy
50,292
+5,560
+12% +$198K ﹤0.01% 1116
2017
Q4 		$1.38M Buy
44,732
+4,920
+12% +$124K ﹤0.01% 1150
2017
Q3 		$956K Sell
39,812
-2,040
-5% -$38.8K ﹤0.01% 1220
2017
Q2 		$702K Sell
41,852
-420
-1% -$7.57K ﹤0.01% 1247
2017
Q1 		$944K Buy
42,272
+20,092
+91% +$416K ﹤0.01% 1189
2016
Q4 		$360K Hold
22,180
– – ﹤0.01% 1317
2016
Q3 		$299K Buy
+22,180
New +$454K ﹤0.01% 1337

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Victory Capital Management's EDIT Position: Q2 2026 in Review

Victory Capital Management increased its Editas Medicine (EDIT) stake by 58% in Q2 2026, buying an estimated $19K and bringing the position to 17,642 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2384.

Victory Capital Management first reported a position in EDIT in Q3 2016 and has held it in 29 quarters since. The position peaked at $46M in Q3 2021. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Victory Capital Management held 17,642 shares of Editas Medicine worth $57.2K as of Q2 2026.
  • Victory Capital Management bought 6,499 Editas Medicine shares in Q2 2026, an estimated $19K.
  • Editas Medicine made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2384 holding.
  • Victory Capital Management first reported a position in Editas Medicine in Q3 2016 and has held it in 29 quarters since.
  • Victory Capital Management's Editas Medicine position peaked at $46M in Q3 2021.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.